Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation.
暂无分享,去创建一个
[1] C Antzelevitch,et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. , 2000, European heart journal.
[2] A. Camm,et al. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. , 2002, American journal of physiology. Heart and circulatory physiology.
[3] P. Rautaharju,et al. Linearly Scaled, Rate‐Invariant Normal Limits for QT Interval: Eight Decades of Incorrect Application of Power Functions , 2002, Journal of cardiovascular electrophysiology.
[4] P. Laguna,et al. Estimation of the QT/RR hysteresis lag. , 2003, Journal of electrocardiology.
[5] J. Ruskin,et al. Drug‐Induced Torsades de Pointes and Implications for Drug Development , 2004, Journal of cardiovascular electrophysiology.
[6] Pablo Laguna,et al. Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction , 2004, IEEE Transactions on Biomedical Engineering.
[7] M Malik,et al. Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation , 2001, Journal of cardiovascular electrophysiology.
[8] C Antzelevitch,et al. Acceleration‐Induced Action Potential Prolongation and Early Afterdepolarizations , 1998, Journal of cardiovascular electrophysiology.
[9] C. Lau,et al. Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate. , 1988, Cardiovascular research.
[10] A J Camm,et al. Evaluation of Drug-Induced QT Interval Prolongation , 2001, Drug safety.